什么是周也荻

核心提示周也荻,男,湘雅二医院眼科医师,博士,助理研究员,硕士生导师,现任职于中南大学。中文名周也荻学位/学历博士职业教师专业方向临床医学任职院校中南大学周也荻个人经历教育经历2013.4-2016.9日本九州大学| 眼科学| 博士学位| 博士研究

最佳答案:

周也荻,男,湘雅二医院眼科医师,博士,助理研究员,硕士生导师,现任职于中南大学。

详情介绍

周也荻,男,湘雅二医院眼科医师,博士,助理研究员,硕士生导师,现任职于中南大学。

中文名
周也荻
学位/学历
博士
职业
教师
专业方向
临床医学
任职院校
中南大学

周也荻个人经历

教育经历

2013.4-2016.9

日本九州大学| 眼科学| 博士学位| 博士研究生毕业

2012.10-2013.3

日本九州大学| 眼科学| Research Student| 研究生(博士预科)

2011.9-2012.9

中南大学| 眼科学| Master student| 硕士研究生(期间出国留学)

2006.9-2011.6

中南大学| 临床医学| 学士学位| 大学本科毕业

工作经历

2016.10-至今

眼科| 中南大学湘雅二医院 助理研究员/医师

社会兼职

湖南省医学会眼科学专业委员会神经眼科和眼病理学组秘书兼职时间:2019/12/01 --至今

中国研究型医院学会神经眼科专业委员会青年委员兼职时间:2019/07/01 --至今

日本眼科学会会员兼职时间:2015/12/01 --至今

《临床与病理杂志》中青年编委兼职时间:2018/02/01 --至今

周也荻研究方向

视网膜/脉络膜新生血管性疾病

眼免疫学

视神经疾病

周也荻学术成果

论文成果

1] Jia Y, Zhou Y*(通讯作者). Involvement of lncRNAs and macrophages: potential regulatory link to angiogenesis . J Immunol Res, 2020,

Liu X, Zhang L, Wang JH, Zeng H, Zou J, Tan W, Zhao H, He Y, Shi J, Yoshida S, Li Y, Zhou Y*(通讯作者). Investigation of circRNA expression Profiles and Analysis of circRNA-miRNA-mRNA Networks in an Animal (Mouse) Model of Age-Related Macular Degeneration. . Cur Eye Res, 2020,

Zhang L, Zeng H, Wang JH, Zhao H, Zhang B, Zou J, Yoshida S, Zhou Y*(通讯作者). Altered Long Non-coding RNAs Involved in Immunological Regulation and Associated with Choroidal Neovascularization in Mice . Int J Med Sci, 2020,

Cao M, Zhang L, Wang JH, Zeng H, Peng Y, Zou J, Shi J, Zhang L, Li Y, Yoshida S, Tang L, Zhou Y*(通讯). Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice . Int J Med Sci, 2019,

Zhang L, Liu S, Wang JH, Zou J, Zeng H, Zhao H, Zhang B, He Y, Shi J, Yoshida S, Zhou Y* (通讯作者). Differential expressions of microRNAs and transfer RNA-derived small RNAs: potential targets of choroidal neovascularization . Current Eye Research, 2019,

Zhang LS#, Zhou YD#(并列一作), Peng YQ, Zeng HL, Yoshida S, Zhao TT.. Identification of altered microRNAs in retinas of mice with oxygen-induced retinopathy . Int J Ophthalmol, 2019,

Zhang L#, Fu X#, Zeng H, Wang JH, Peng Y, Zhao H, Zou J, Zhang L, Li Y, Yoshida S, Zhou Y*(通讯作者). Microarray Analysis of Long Non-Coding RNAs and Messenger RNAs in a Mouse Model of Oxygen-Induced Retinopathy . Int J Med Sci, 2019, 16(4): 537-547

Li Y, Zhou Y*(通讯作者). Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases . Tohoku J Exp Med, 2019,

Peng Y#, Cao M#, Yoshida S,Zhang L,Zeng H, Zou J,Kobayashi Y,Nakama T, Shi J, Jia S, Zhou Y*(通讯作者). Attenuation of periostin in retinal Müller glia by TNF-α and IFN-γ . Int J Ophthalmol, 2019,

Zhou YD*, Yoshida S*, Peng YQ, Kobayashi Y, Zhang LS, Tang LS. Diverse roles of macrophages in intraocular neovascular diseases: a review . Int J Ophthalmol, 2017,

Zhou Y, Yoshida S*, Kubo Y, Yoshimura T, Kobayashi Y, et al. Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization . Mol Med Rep, 2017,

Zhou Y, Yoshida S*, Kubo, Y, Kobayashi Y, Nakama T, et al.. Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy . Sci Rep, 2016,

Zhou Y, Yoshida S*, Nakao S, Yoshimura T, Kobayashi Y, et al.. M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy . Invest Ophthalmol Vis Sci, 2015,

Peng Y, Tang L, Zhou Y* (通讯作者). Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases. . Ophthalmic Res, 2017,

Peng Y#, Zhao Y#, Hu W, Hu Y, He Y, Zhou Y* (通讯作者). Reduction of retinal nerve fiber layer thickness in vigabatrin-exposed patients: A meta-analysis . Clin Neurol Neurosurg, 2017,

Peng YQ, Tang LS, Yoshida S, Zhou YD* (通讯作者). Applications of CRISPR/Cas9 in Retinal Degenerative Diseases . Int J Ophthalmol, 2017,

Zhang L, Liang Y, Zhou Y, Zeng H, Jia S*, Shi J*. A Missense Mutation in GJA8 Encoding Connexin 50 in a Chinese Pedigree with Autosomal Dominant Congenital Cataract. . Tohoku J Exp Med, 2018,

Wada I, Yoshida S*, Kobayashi Y, Zhou Y, Ishikawa K, et al. Quantifying metamorphopsia with M-CHARTS in patients with idiopathic macular hole. . Clin Ophthalmol, 2017,

Nakama T, Yoshida S*, Ishikawa K, Kubo Y, Kobayashi Y, Zhou Y, et al.. Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization. . Mol Ther Nucleic Acids, 2017,

Wang JH, Wang R, Lee JH, Iao TWU, Hu X, et al.. Public Attitudes toward Gene Therapy in China. . Mol Ther Methods Clin Dev, 2017,

Kobayashi Y, Yoshida S*, Zhou Y, Nakama T, Ishikawa K, et al.. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy. . Mol Vis, 2016,

Kobayashi Y, Yoshida S, Zhou Y, Nakama T, Ishikawa K, et al.. Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV. . Lab Invest, 2016,

Yamaguchi M, Nakao S*, Arita R, Kaizu Y, Arima M, Zhou Y, et al.. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia. . Invest Ophthalmol Vis Sci, 2016,

Ishikawa K, Yoshida S*, Kobayashi Y, Zhou Y, Nakama T, et al.. Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy. . Invest Ophthalmol Vis Sci, 2015,

Yoshida S*, Kubo Y, Kobayashi Y, Zhou Y, Nakama T, et al.. Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular edema. . Br J Ophthalmol, 2015,

Yoshida S, Kobayashi Y, Nakama T, Zhou Y, Ishikawa K, et al.. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: Implications for M2 macrophage-involving fibrovascular membrane formation. . Br J Ophthalmol, 2015,

Kobayashi Y, Yoshida S*, Nakama T, Zhou Y, Ishikawa K, et al.. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: Possible involvement of periostin. . Br J Ophthalmol, 2015,

Nakama T, Yoshida S*, Ishikawa K, Kobayashi Y, Zhou Y, et al.. Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. . Gene Ther, 2015.

科研项目

早产儿视网膜病变患者环状RNA表达谱及生物标记物的研究及开发

IL-19调控巨噬细胞M2极化及微血管内皮细胞功能在视网膜新生血管形成中的作用和机制研究

干扰素γ诱导巨噬细胞M1极化调控视网膜新生血管的作用和机制

专利成果

一种动物实验用密闭仓

一种定量定位的扣盖式滴眼药水瓶

一种睑板腺按摩器

 
友情链接
鄂ICP备19019357号-22